• Self-care and the Rapidly Changing Market of Obesity Drugs
    by Ed Kelley, Ph.D. on May 31, 2023 at 7:17 pm

    Could 5 new anti-obesity drugs recently approved by the FDA and other regulators make a difference in one of the world’s biggest public health challenges? The quick answer is yes, for some patients this new group of weight management drugs could be life-changing. But the newly approved anti-obesity drugs – and additional similar drugs that are likely to follow in the near future -- are not a panacea. They will not replace healthy eating, nor enable patients to reach their ideal weight without effort.

  • The End of COVID-19? Not for Everybody.
    by Ed Kelley, Ph.D. on April 12, 2023 at 12:53 pm

    We are now entering our fourth spring of the global COVID pandemic. But this spring looks far different from the last three. April of 2020 saw the world scrambling to get public health measures in place while still maintaining essential health services.

  • The Long Road with Long COVID
    by Ed Kelley, Ph.D. on March 30, 2023 at 3:50 pm

    With infections dropping, COVID-19 seems to have become obsolete. What’s next?

  • When Business as Usual is Bad for Public Health
    by GLOBE by ApiJect on February 22, 2023 at 1:45 pm

    By Don Berwick and Ed Kelley

  • Vaccines Beyond COVID-19
    by Ed Kelley, Ph.D. on November 1, 2022 at 1:46 pm

    mRNA technology was launched originally not for COVID-19 but for personalized vaccines for chronic diseases like cancer. Can we do a better job this second time around?

  • Leading After Emergency
    by Ed Kelley, Ph.D. on September 1, 2022 at 2:25 pm

    After pages of goals and recommendations on responding to COVID-19 and preparing for the next pandemic, one thing is still lacking: leadership